caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1548681513

Rubee GonzalezPHYSICIAN ASSISTANT

Physician AssistantPort Orchard, WAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
107
Beneficiaries
—
Total drug cost
$858
Distinct drugs
7
Brand share
46.7%
Top prescribed drugs
Amoxicillin/Potassium Clav21 claims
Cephalexin17 claims
Azithromycin16 claims
Nitrofurantoin Monohyd/M-Cryst16 claims
Hydrocodone/Acetaminophen13 claims
REFERRAL NETWORK

Where Rubee Gonzalez's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
COMMUNITY HEALTH CARE73125
Laboratory Corporation Of America
Clinical Laboratory · Seattle, WA
1529
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
169
Unique beneficiaries
—
Total services
170
Distinct HCPCS
4
Medicare payment
$13K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 2,882 Physician Assistant providers in WA — below median (cohort median 241).